New T-FINDER Platform Provides Deep Insights Into T Cell Responses Against Novel Cancer Vaccine
By API User
Researchers at the BioMed X Institute and the Universitätsmedizin Mannheim just published the results of their collaboration around a new neoepitope vaccine in diffuse midline glioma in Science Advances. HEIDELBERG, GERMANY / ACCESSWIRE / February 6, 2024 / BioMed X and the Universitätsmedizin Mannheim announced today the publication of two manuscripts in the field of … Continued